@dansfera: That massive stock surge after a strong Phase 2 biotech readout? It's often a mirage! 🤯 This expert insight drops a serious truth bomb: Phase 2 success, particularly from single-arm studies without a control group, frequently *does not* translate to a win in Phase 3. Don't get caught holding the bag when the rigorous data proves the initial excitement was premature. Know the science behind the spike! \#BiotechInvesting \#StockMarketRisk \#PharmaStocks \#ClinicalTrials \#InvestmentTips

dansfera

Open In TikTok:

Region: US

Tuesday 09 December 2025 23:05:32 GMT